Antiplatelet and antithrombotic activities of salvianolic acid A

Thrombosis Research

Volumn 126, Issue 1, 2010, Pages

  Fan, Hua Ying ^a,b,c   Fu, Feng Hua ^b   Yang, Ming Yan ^c   Xu, Hui ^b,c   Zhang, Ai Hong ^c   Liu, Ke ^a,b,c  

^a JILIN UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

^c Shandong Target Drug Research Co Ltd   (China)

Author keywords

Antiplatelet; Antithrombotic; Coagulation; Hemorheology; Salvianolic acid A

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; CYCLIC AMP; FIBRINOGEN; HEPARIN; SALVIANOLIC ACID A; THROMBIN; UNCLASSIFIED DRUG; CAFFEIC ACID DERIVATIVE; LACTIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ANTIPLATELET ACTIVITY; ANTITHROMBOTIC ACTIVITY; ARTERIOVENOUS SHUNT; ARTICLE; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING; BLOOD RHEOLOGY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RADIOIMMUNOASSAY; RAT; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; SPRAGUE DAWLEY RAT; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CAFFEIC ACIDS; HUMANS; LACTATES; MALE; PLATELET AGGREGATION; RATS; RATS, SPRAGUE-DAWLEY; THROMBIN; THROMBOSIS;

EID: 77953120701     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.04.006     Document Type: Article

References (35)

1. Fuster V., Steele P.M., and Chesebro J.H. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J AM Coll Cardiol (1985) 175B-184B SV
2. Packham M.A., and Mustard J.F. The role of platelets in the development and complication of atherosclerosis. Semin Hematol 23 (1986) 8-26
3. Ruggeri Z.M. Mechanisms initiating platelet thrombus formation. Thromb Haemost 78 (1997) 611-616
4. Banno H., Kawazura H., Yutaka T., Sakuma N., Kitamori T., Hosoya J., et al. Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein IIb/IIIa receptor antagonist. Eur J Pharmacol 367 (1999) 275-282
5. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
6. De Meyer S.F., Vanbooelbeke K., Broos K., Salles I.I., and Deckmyn H. Antiplatelet drugs. Brit J Haematol 142 (2008) 515-528
7. Yun-Choi H.S., Pyo M.K., Park K.M., Chang K.C., and Lee D.H. Antithrombotic effects of YS-49 and YS-51-1-Naphthylmethyl analogs of higenamine. Thromb Res 104 (2001) 249-255
8. Cheng T.O. Cardiovascular effects of Danshen. Int J Cardiol 121 (2007) 9-22
9. Cheng T.O. Danshen: A versatile Chinese herbal drug for the treatment of coronary heart disease. Int J Cardiol 113 (2006) 437-438
10. Cheng T.O. Danshen: What every cardiologist should know about this Chinese herbal drug. Int J Cardiol 110 (2006) 411-412
11. Liu G.T., Zhang T.M., Wang B.E., and Wang Y.W. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol 43 (1992) 147-152
12. Shang H.C., Cao H.B., Wang Y., Zhang Y., Wu Y., Jiang Z.H., et al. Protective effects of salvianolic acid A on focal cerebral ischemia in rats. J Pharm Clin Tradit Chin Med 23 (2007) 15-17
13. Qi C. Pharmacology Research Methodology of Traditional Chinese Medicine (1996), People's Health Publishing House, Beijing 522
14. Chang T.S., Kim H.M., Lee K.S., Khil L.Y., Mar W.C., Ryu C.K., et al. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl) amino]-3-chloro-1, 4-naphthalenedione (NQ-Y15) in rat platelets. Biochem Pharmacol 54 (1997) 259-268
15. Born G.V.R., and Cross M.J. Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate. J Physiol 170 (1964) 394-414
16. Walsh P.N., Mills D.C.B., and White J.G. Metabolism and function of human platelets washed by albumin density gradient separation. Brit J Haematol 36 (1977) 281
17. Umar A., Boisseau M., Yusup A., Upur H., Begaud B., and Moore N. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model. Fund Clin Pharmacol 18 (2004) 559-563
18. Umar A., Guerin V., Renard M., Boisseau M., Garreau C., Begaud B., et al. Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo. Thromb Res 110 (2003) 135-140
19. Chen X.P., Wang X.W., Zhang Y.Y., Xu X.F., Ka W.B., Sun D.G., et al. Effect of ethanol extract of terminalia chebula on microrheological characteristics in acute blood stasis model rat. Chin J Hemorh 17 (2007) 525-528
20. Gao R., Zhang Y., Wang S.C., XU L., and Zhang Q.S. Pharmacokinetics and pharmacodynamics research on salvianolic acid B in the healthy volunteers. Chin J Clin Pharmacol Ther 11 (2004) 1209-1212
21. Gao H., Li X.H., Li C.Y., and Lu J.M. Effect of salvianolic acid B on the platelet aggregation and adhesiveness in healthy volunteers. J Bengbu Med Coll 32 (2007) 514-516
22. Jackson S.P., Nesbitt W.S., and Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 1 (2003) 1602-1612
23. Farndale R.W., Sixma J.J., Barnes M.J., and De Groot P.G. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2 (2004) 561-573
24. Lee K.S., Jin Y.R., Lee J.J., Lim Y., Son D.J., Lee C.K., et al. Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor. Pharmacol Res 53 (2006) 265-270
25. Kahner B.N., Shankar H., Murugappan S., Prasad G.L., and Kunapuli S.P. Nucleotide receptor signaling in platelets. J Thromb Haemost 4 (2006) 2317-2326
26. 12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 112 (2003) 398-406
27. Hsiao G., Shen M.Y., Chou D.S., Chang Y., Lee L.W., Lin C.H., et al. Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies. Eur J Pharmacol 487 (2004) 159-166
28. Zhang Y.H., Chung K.H., Ryu C.K., Ko M.H., Lee M.K., and Yun Y.P. Antiplatelet effect of 2-Chloro-3-(4-acetophenyl)-amino-1, 4-naphthoquinone (NQ301): A possible mechanism through inhibition of intracellular Ca2+ mobilization. Biol Pharm Bull 24 (2001) 618-622
29. Smith J.R., and White A.M. Fibrin, red cell and platelet interactions in an experimental model of thrombosis. Br J Pharmacol 77 (1982) 29-38
30. Damiano B.P., Mitchell J.A., Gardino E., Corcoran T., Haertlein B.J., Garavillla L.D., et al. Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist. Thromb Res 104 (2001) 113-126
31. Baskurt O.K., and Meiselman H.J. Blood Rheology and Hemodynamics. Semin Thromb Hemost 29 (2003) 435-450
32. Jan K.M., Chien S., and Bigger J.T. Observations on blood viscosity changes after acute myocardial infarction. Circulation 51 (1975) 1079-1084
33. Lowe G.D.O., Lee A.J., Rumley A., Price J.F., and Fowkes F.G.R. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Brit J Haematol 96 (1997) 168-173
34. Grotta J., Ackerman R., Correia J., Fallick G., and Chang J. Whole blood viscosity parameters and cerebral blood flow. Stroke 13 (1982) 296-301
35. Muldoon M.F., Herbert T.B., Patterson S.M., Kameneva M., Raible R., and Manuck S.B. Effects of acute psychological stress on serum lipid levels, hemoconcentration, and blood viscosity. Arch Intern Med 155 (1995) 615-620